David L. Horn

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

David L. Horn, Elias Anaissie, Jay A. Fishman et al. · Clinical Infectious Diseases · 2009 · 950 citations · Full text

Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

Peter G. Pappas, C. M. F. Rotstein, Robert F. Betts et al. · Clinical Infectious Diseases · 2007 · 628 citations · Full text

Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008

Michael A. Pfaller, David R. Andes, Daniel J. Diekema et al. · PLoS ONE · 2014 · 398 citations · Full text

Path Alliance, Antifungal Agent, Health Sciences +13

Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry

William J. Steinbach, Kieren A. Marr, Elias Anaissie et al. · Journal of Infection · 2012 · 344 citations

Diagnostic Mycology, Invasive Aspergillosis, Fungal Pathogen +6

Twenty years of therapy for HIV-1 infection

Roger J. Pomerantz, David L. Horn · Nature Medicine · 2003 · 281 citations

Treatment And Prevention, Human Retrovirus, Antiviral Therapy +4